Effect of genetic background on phenotype variability in transgenic mouse models of amyotrophic lateral sclerosis: A window of opportunity in the search for genetic modifiers

References

• Majoor-Krakauer D, Willems PJ, Hofman A. Genetic epidemiology of amyotrophic lateral sclerosis. Clin Genet. 2003; 63:83–101.
   PubMed Web of Science ®Google Scholar
• Brown RH Jr, Robberecht W. Amyotrophic lateral sclerosis: pathogenesis. Semin Neurol. 2001;21:131–9.
   PubMed Web of Science ®Google Scholar
• Cleveland DW. From Charcot to SOD1: mechanisms of selective motor neuron death in ALS. Neuron. 1999;24:515–20.
   PubMed Web of Science ®Google Scholar
• Cleveland DW, Rothstein JD. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci. 2001;2:806–19.
   PubMed Web of Science ®Google Scholar
• Rosen AD. Amyotrophic lateral sclerosis: clinical features and prognosis. Arch Neurol. 1978;35:638–42.
   PubMed Web of Science ®Google Scholar
• Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med. 2001;344:1688–700.
   PubMed Web of Science ®Google Scholar
• Shaw PJ. Mechanisms of cell death and treatment prospects in motor neuron disease. Hong Kong Med J. 2001; 7:267–80.
   PubMedGoogle Scholar
• Tandan R, Bradley WG. Amyotrophic lateral sclerosis: Part 1. Clinical features, pathology, and ethical issues in management. Ann Neurol. 1985;18:271–80.
   PubMed Web of Science ®Google Scholar
• Byrne S, Walsh C, Lynch C, Bede P, Elamin M, Kenna K, . Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2010;Nov 3. (Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Valdmanis PN, Daoud H, Dion PA, Rouleau GA. Recent advances in the genetics of amyotrophic lateral sclerosis. Curr Neurol Neurosci Rep. 2009;9:198–205.
   PubMed Web of Science ®Google Scholar
• Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, . Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59–62.
   PubMed Web of Science ®Google Scholar
• Siddique T, Figlewicz DA, Pericak-Vance MA, Haines JL, Rouleau G, Jeffers AJ, . Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic locus heterogeneity. N Engl J Med. 1991; 324:1381–4.
   PubMed Web of Science ®Google Scholar
• Deng HX, Hentati A, Tainer JA, Iqbal Z, Cayabyab A, Hung WY, . Amyotrophic lateral sclerosis and structural defects in Cu/Zn superoxide dismutase. Science. 1993;261: 1047–51.
   PubMed Web of Science ®Google Scholar
• Al-Chalabi A, Andersen PM, Chioza B, Shaw C, Sham PC, Robberecht W, . Recessive amyotrophic lateral sclerosis families with the D90A-SOD1 mutation share a common founder: evidence for a linked protective factor. Hum Mol Genet. 1998;7:2045–50.
   PubMed Web of Science ®Google Scholar
• Cudkowicz ME, McKenna-Yasek D, Sapp PE, Chin W, Geller B, Hayden DL, . Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Ann Neurol. 1997;41:210–21.
   PubMed Web of Science ®Google Scholar
• Andersen PM, Nilsson P, Keranen ML, Forsgren L, Hagglund J, Karlsborg M, . Phenotypic heterogeneity in motor neuron disease patients with Cu/Zn superoxide dismutase mutations in Scandinavia. Brain. 1997;120: 1723–37.
   PubMed Web of Science ®Google Scholar
• van Es MA, van Vught PW, Veldink JH, Andersen PM, Birve A, Lemmens R, . Analysis of FGGY as a risk factor for sporadic amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2009;10:441–7.
   PubMed Web of Science ®Google Scholar
• Sha Q, Zhang Z, Schymick JC, Traynor BJ, Zhang S. Genome-wide association reveals three SNPs associated with sporadic amyotrophic lateral sclerosis through a two-locus analysis. BMC Med Genet. 2009;10:86.
   PubMed Web of Science ®Google Scholar
• Chio A, Schymick JC, Restagno G, Scholz SW, Lombardo F, Lai SL, . A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis. Hum Mol Genet. 2009;18:1524–32.
   PubMed Web of Science ®Google Scholar
• Cronin S, Tomik B, Bradley DG, Slowik A, Hardiman O. Screening for replication of genome-wide SNP associations in sporadic ALS. European Journal of Human Genetics. 2009;17:213–8.
   PubMed Web of Science ®Google Scholar
• Dupre N, Valdmanis P. Genome-wide association studies in amyotrophic lateral sclerosis. Eur J Hum Genet. 2009;17: 137–8.
   PubMed Web of Science ®Google Scholar
• Mougeot JL, Richardson-Milazi S, Brooks BR. Whole-genome association studies of sporadic amyotrophic lateral sclerosis: are retroelements involved? Trends Mol Med. 2009;15:148–58.
   PubMed Web of Science ®Google Scholar
• Brannstrom T, Ernhill K, Marklund S, Nilsson R. Transgenic mice homozygous for the Asp90Ala human SOD1 mutation develop ALS clinically and histologically. Soc Neurosci. 1998; 188:1.
   Google Scholar
• Bruijn LI, Becher MW, Lee MK, Anderson KL, Jenkins NA, Copeland NG, . ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron. 1997;18:327–38.
   PubMed Web of Science ®Google Scholar
• Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, . Motor neuron degeneration in mice that express a human Cu/Zn superoxide dismutase mutation. Science. 1994;264:1772–5.
   PubMed Web of Science ®Google Scholar
• Ripps ME, Huntley GW, Hof PR, Morrison JH, Gordon JW. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A. 1995;92:689–93.
   PubMed Web of Science ®Google Scholar
• Wong PC, Pardo CA, Borchelt DR, Lee MK, Copeland NG, Jenkins NA, . An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron. 1995;14:1105–16.
   PubMed Web of Science ®Google Scholar
• Wang J, Xu G, Slunt HH, Gonzales V, Coonfield M, Fromholt D, . Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNA. Neurobiol Dis. 2005;20:943–52.
   PubMed Web of Science ®Google Scholar
• Dal Canto MC, Gurney ME. Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. Am J Pathol. 1994;145: 1271–9.
   PubMed Web of Science ®Google Scholar
• Dal Canto MC, Gurney ME. Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu/Zn SOD, and in mice overexpressing wild-type human SOD: a model of familial amyotrophic lateral sclerosis (FALS). Brain Res. 1995;676:25–40.
   PubMed Web of Science ®Google Scholar
• Dal Canto MC, Gurney ME. A low expressor line of transgenic mice carrying a mutant human Cu/Zn superoxide dismutase (SOD1) gene develops pathological changes that most closely resemble those in human amyotrophic lateral sclerosis. Acta Neuropathol (Berl). 1997;93:537–50.
   PubMed Web of Science ®Google Scholar
• Tu PH, Raju P, Robinson KA, Gurney ME, Trojanowski JQ, Lee VM. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Proc Natl Acad Sci U S A. 1996;93:3155–60.
   PubMed Web of Science ®Google Scholar
• Gurney ME, Cutting FB, Zhai P, Doble A, Taylor CP, Andrus PK, . Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann Neurol. 1996;39:147–57.
   PubMed Web of Science ®Google Scholar
• Alexander GM, Erwin KL, Byers N, Deitch JS, Augelli BJ, Blankenhorn EP, . Effect of transgene copy number on survival in the G93A-SOD1 transgenic mouse model of ALS. Brain Res Mol Brain Res. 2004;130:7–15.
   PubMedGoogle Scholar
• Chiu AY, Zhai P, Dal Canto MC, Peters TM, Kwon YW, Prattis SM, . Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis. Mol Cell Neurosci. 1995;6:349–62.
   PubMed Web of Science ®Google Scholar
• Liu R, Althaus JS, Ellerbrock BR, Becker DA, Gurney ME. Enhanced oxygen radical production in a transgenic mouse model of familial amyotrophic lateral sclerosis. Ann Neurol. 1998;44:763–70.
   PubMed Web of Science ®Google Scholar
• Kunst CB, Messer L, Gordon J, Haines J, Patterson D. Genetic mapping of a mouse modifier gene that can prevent ALS onset. Genomics. 2000;70:181–9.
   PubMed Web of Science ®Google Scholar
• Messer A, Manley K, Plummer JA. An early-onset congenic strain of the motor neuron degeneration (mnd) mouse. Mol Genet Metab. 1999;66:393–7.
   PubMed Web of Science ®Google Scholar
• Cox GA, Mahaffey CL, Frankel WN. Identification of the mouse neuromuscular degeneration gene and mapping of a second site suppressor allele. Neuron. 1998;21:1327–37.
   PubMed Web of Science ®Google Scholar
• Frankel WN. Mouse strain backgrounds: more than black and white. Neuron. 1998;20:183.
   PubMed Web of Science ®Google Scholar
• Bradley A. Mining the mouse genome. Nature. 2002;420: 512–4.
   PubMed Web of Science ®Google Scholar
• Waterston RH, Lindblad-Toh K, Birney E, Rogers J, Abril JF, Agarwal P, . Initial sequencing and comparative analysis of the mouse genome. Nature. 2002;420:520–62.
   PubMed Web of Science ®Google Scholar
• Paigen K, Eppig JT. A mouse phenome project. Mamm Genome. 2000;11:715–7.
   PubMed Web of Science ®Google Scholar
• Heiman-Patterson TD, Deitch JS, Blankenhorn EP, Erwin KL, Perreault MJ, Alexander BK, . Background and gender effects on survival in the TgN(SOD1-G93A)1Gur mouse model of ALS. J Neurol Sci. 2005;236:1–7.
   PubMed Web of Science ®Google Scholar
• Camu W, Khoris J, Moulard B, Salachas F, Briolotti V, Rouleau GA, . Genetics of familial ALS and consequences for diagnosis. French ALS Research Group. J Neurol Sci. 1999;165 (Suppl 1):S21–6.
   PubMedGoogle Scholar
• Heiman-Patterson TD, Deitch JS, Blankenhorn EP, Erwin KL, Perreault MJ, Alexander BK, . Background and gender effects on survival in the G93A-SOD1 transgenic mouse model of ALS. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003;4:118.
   PubMedGoogle Scholar
• Wooley CM, Sher RB, Kale A, Frankel WN, Cox GA, Seburn KL. Gait analysis detects early changes in transgenic SOD1-G93A mice. Muscle Nerve. 2005;32:43–50.
   PubMed Web of Science ®Google Scholar
• Veldink JH, Bar PR, Joosten EAJ, Otten M, Wokke JHJ, van den Berg LH. Sexual differences in onset of disease and response to exercise in a transgenic model of ALS. Neuromuscul Disord. 2003;13:737–43.
   PubMed Web of Science ®Google Scholar
• Mathews CE, Dunn BD, Hannigan MO, Huang CK, Leiter EH. Genetic control of neutrophil superoxide production in diabetes-resistant ALR/Lt mice. Free Radic Biol Med. 2002;32:744–51.
   PubMed Web of Science ®Google Scholar
• Mathews CE, Leiter EH. Resistance of ALR/Lt islets to free radical-mediated diabetogenic stress is inherited as a dominant trait. Diabetes. 1999;48:2189–96.
   PubMed Web of Science ®Google Scholar
• Mathews CE, Leiter EH. Constitutive differences in antioxidant defense status distinguish alloxan-resistant and alloxan-susceptible mice. Free Radic Biol Med. 1999;27:449–55.
   PubMed Web of Science ®Google Scholar
• Mathews CE, Suarez-Pinzon WL, Baust JJ, Strynadka K, Leiter EH, Rabinovitch A. Mechanisms underlying resistance of pancreatic islets from ALR/Lt mice to cytokine-induced destruction. J Immunol. 2005;175:1248–56.
   PubMed Web of Science ®Google Scholar
• Ende N, Weinstein F, Chen R, Ende M. Human umbilical cord blood effect on sod mice (amyotrophic lateral sclerosis). Life Sci. 2000;67:53–9.
   PubMed Web of Science ®Google Scholar
• Yi FH, Lautrette C, Vermot-Desroches C, Bordessoule D, Couratier P, Wijdenes J, . In vitro induction of neuronal apoptosis by anti-Fas antibody-containing sera from amyotrophic lateral sclerosis patients. J Neuroimmunol. 2000; 109:211–20.
   PubMed Web of Science ®Google Scholar
• Nguyen MD, Julien JP, Rivest S. Induction of proinflammatory molecules in mice with amyotrophic lateral sclerosis: no requirement for proapoptotic interleukin-1beta in neurodegeneration. Ann Neurol. 2001;50:630–9.
   PubMed Web of Science ®Google Scholar
• Beers DR, Henkel JS, Zhao W, Wang J, Appel SH. CD4+T-cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS. Proc Natl Acad Sci U S A. 2008; 105:15558–63.
   PubMed Web of Science ®Google Scholar
• Papadimitriou D, Le Verche V, Jacquier A, Ikiz B, Przedborski S, Re DB. Inflammation in ALS and SMA: sorting out the good from the evil. Neurobiol Dis. 2010;37:493–502.
   PubMed Web of Science ®Google Scholar
• Henkel JS, Beers DR, Zhao W, Appel SH. Microglia in ALS: the good, the bad, and the resting. J Neuroimmune Pharmacol. 2009;4:389–98.
   PubMed Web of Science ®Google Scholar